Models &
Molecules
Inside the digital transformation of drug discovery

Iddo Weiner: Data, moats, and open science: Building scalable AI applications for bio
About the podcast
At the intersection of computation and biology, Models & Molecules explores how data, algorithms, and science come together to design the medicines of tomorrow.
Each episode features candid conversations with the people shaping this transformation, from pharma R&D leaders to computational biologists and AI innovators, about the ideas, challenges, and technologies redefining how drugs are discovered.
Produced by ENPICOM, Models & Molecules offers a rare look behind the buzzwords of AI-driven discovery, uncovering the practical realities, lessons learned, and moments of insight that emerge when biology meets computation.
Previous episodes

Inside Boltz's open-source bet on the future of AI-driven drug discovery
June 2, 2026
From novel binder design to the realities of AI in complex therapeutics
April 14, 2026
From lab-in-the-loop to zero-shot: The role of cloud and AI agents
March 3, 2026
Navigating the convergence of tech and pharma
January 28, 2026
From rabies to COVID: Antibody discovery in the age of AI
December 16, 2025
Taking risks and driving innovation in biopharma
November 4, 2025Never miss an episode
Subscribe for monthly insights from the biologics R&D leaders shaping drug discovery.
Thank you for signing up!